Endometrioid Adenocarcinoma, Variant with Squamous Differentiation

Endometrioid Adenocarcinoma, Variant with Squamous Differentiation — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01210222	Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer	completed	Phase 2	35	Gynecologic Oncology GroupNETWORK	1	Feb 23, 2018	clinicaltrials
NCT00064025	Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus	completed	Phase 2	75	Gynecologic Oncology GroupNETWORK	1	Apr 11, 2016	clinicaltrials